R H Verheijen

Summary

Affiliation: University Hospital Vrije Universiteit
Country: The Netherlands

Publications

  1. ncbi request reprint Sentinel node detection in cervical cancer
    R H Verheijen
    Department of Obstetrics and Gynecology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Obstet Gynecol 96:135-8. 2000
  2. ncbi request reprint Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA
    P J Snijders
    Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Cancer Res 58:3812-8. 1998
  3. ncbi request reprint Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
    R P Zweemer
    Department of Obstetrics and Gynaecology, VU Medical Center, Amsterdam, The Netherlands
    Lab Invest 81:1363-70. 2001
  4. ncbi request reprint Survival analysis in familial ovarian cancer, a case control study
    R P Zweemer
    Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    Eur J Obstet Gynecol Reprod Biol 98:219-23. 2001
  5. pmc A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings
    M V Jacobs
    Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Br J Cancer 81:114-21. 1999
  6. ncbi request reprint Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p
    I van Zanten-Przybysz
    Department of Obstetrics and Gynecology, University Hospital, Vrije Universiteit, Amsterdam, The Netherlands
    Int J Cancer 92:106-14. 2001
  7. ncbi request reprint Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias
    J P Baak
    Department of Pathology, Free University Medical Center, Amsterdam, The Netherlands
    Am J Surg Pathol 25:930-5. 2001
  8. ncbi request reprint Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes
    C J Vennegoor
    Department of Obstetrics and Gynecology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Cancer Lett 116:93-101. 1997
  9. ncbi request reprint Ovarian cancer in female-to-male transsexuals: report of two cases
    J J Hage
    Department of Plastic and Reconstructive Surgery, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands
    Gynecol Oncol 76:413-5. 2000
  10. pmc Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
    T D de Gruijl
    Department of Pathology, Free University Hospital, Amsterdam, The Netherlands
    Br J Cancer 79:1127-32. 1999

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Sentinel node detection in cervical cancer
    R H Verheijen
    Department of Obstetrics and Gynecology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Obstet Gynecol 96:135-8. 2000
    ..Sentinel node detection has not yet proved feasible in tumors, such as cervical cancer, that drain to deep pelvic lymph nodes...
  2. ncbi request reprint Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA
    P J Snijders
    Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Cancer Res 58:3812-8. 1998
    ....
  3. ncbi request reprint Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
    R P Zweemer
    Department of Obstetrics and Gynaecology, VU Medical Center, Amsterdam, The Netherlands
    Lab Invest 81:1363-70. 2001
    ..These and other yet unknown suppressor genes may be involved in a specific carcinogenic pathway for familial ovarian cancer and may explain the distinct clinical presentation and behavior of familial ovarian cancer...
  4. ncbi request reprint Survival analysis in familial ovarian cancer, a case control study
    R P Zweemer
    Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    Eur J Obstet Gynecol Reprod Biol 98:219-23. 2001
    ..This may have important implications for the management and prevention of familial ovarian cancer...
  5. pmc A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings
    M V Jacobs
    Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Br J Cancer 81:114-21. 1999
    ..Therefore, accurate measurements on viral DNA load in cervical scrapings require corrections for these phenomena, which can be achieved by application of this fully quantitative approach...
  6. ncbi request reprint Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p
    I van Zanten-Przybysz
    Department of Obstetrics and Gynecology, University Hospital, Vrije Universiteit, Amsterdam, The Netherlands
    Int J Cancer 92:106-14. 2001
    ..The i.p. route could be advantageous with respect to bone marrow toxicity since the AUC was significantly lower for the i.p. route. However, within 2 days post-injection, the blood clearance followed the same pattern for both routes...
  7. ncbi request reprint Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias
    J P Baak
    Department of Pathology, Free University Medical Center, Amsterdam, The Netherlands
    Am J Surg Pathol 25:930-5. 2001
    ..S. $50 per case)...
  8. ncbi request reprint Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes
    C J Vennegoor
    Department of Obstetrics and Gynecology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Cancer Lett 116:93-101. 1997
    ..IgG2 antibodies against p53 suggest p53-specific CD4+ T helper 1 cell activity in some of the ovarian cancer patients...
  9. ncbi request reprint Ovarian cancer in female-to-male transsexuals: report of two cases
    J J Hage
    Department of Plastic and Reconstructive Surgery, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands
    Gynecol Oncol 76:413-5. 2000
    ..Ovarium cancer is the fifth most common cause of cancer-related death in women and is the most common fatal gynecologic malignancy. So far, ovarium carcinoma has not been reported to have occurred in female-to-male transsexuals...
  10. pmc Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
    T D de Gruijl
    Department of Pathology, Free University Hospital, Amsterdam, The Netherlands
    Br J Cancer 79:1127-32. 1999
    ..The apparently unimpaired zeta chain expression within draining lymph nodes suggests that local tumour-derived factors at the primary site are instrumental in zeta chain down-regulation...
  11. ncbi request reprint Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
    J M Piek
    Department of Obstetrics and Gynaecology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    J Pathol 195:451-6. 2001
    ....